中国生物工程杂志

［1］ Arvin A M.Varicellazoster Virus//David M K,Peter M H.Fields Virology.Philadelphia:LippincottRaven Publishers,2001:27312767. 
［2］ Hosoda F, Nishimura S, Uchida H, et al. An F factor based cloning system for large DNA fragments. Nucleic Acids Res, Res. 1990,18(13):3863 3869. 
［3］ Shizuya H, Birren B, Kim U J, et al. Cloning and stable maintenance of 300 kilobase pair fragments of human DNA in Escherichia coli using an F factor based vector. Proc Natl Acad Sci USA, 1992,89(18):8794 8797. 
［4］ Ioannou P A, Amemiya C T, Garnes J,et al. A new bacteriophage P1 derived vector for the propagation of large human DNA fragments. Nat Genet, 1994,6(1):84 89. 
［5］ Woo S S, Jiang J, Gill B S, Paterson A H, et al. Construction and characterization of a bacterial artificial chromosome library of Sorghum bicolor. Nucleic Acids Res,1994,22(23):4922 4931. 
［6］ Hess N, Franz T, Kollek R, et al. Molecular cloning of Rauscher spleen focus forming virus and biological properties of the cloned virus. J Gen Virol,1984,65 (12):2225 2235. 
［7］ Messerle M，Cmkovic I，Hanunerschmidt W，et al．Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromotome. Prec Nad Acad Sci USA，1997，94(26)：14759 14763. 
［8］ Zhou F, Li Q, Gao S J. A sequence independent in vitro transposon based strategy for efficient cloning of genomes of large DNA viruses as bacterial artificial chromosomes. Nucleic Acids Res, 2009,37(1):e2. 
［9］ Creed R, Satyaprakash A, Ravanfar P. Varicella zoster vaccines. Dermatol Ther, 2009,22(2):143 149. 
［10］ Nagaike K, Mori Y, Gomi Y, et al. Cloning of the varicella zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine,2004,22(29 30):4069 4074. 
［11］ Yoshii H, Somboonthum P,Takahashi M, et al. Cloning of full length genome of varicella zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus.Vaccine,2007,25(27):5006 5012. 
［12］ Zhang Z, Rowe J, Wang W, et al. Genetic analysis of varicella zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol,2007,81(17):90249033. 
［13］ Cohen J I, Seidel K E. Generation of varicella zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci U S A,1993,90(15):7376 7380. 
［14］ Niizuma T, Zerboni L, Sommer M H, et al. Construction of varicella zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID hu mouse model. J Virol, 2003,77(10):6062 6065. 
［15］ Tischer B K, Kaufer B B, Sommer M, et al. A self excisable infectious bacterial artificial chromosome clone of varicella zoster virus allows analysis of the essential tegument protein encoded by ORF9. J Virol, 2007,81(23):13200 13208. 
［16］ Tischer B K,von Einem J,Kaufer B, et al.Two step red mediated recombination for versatile high efficiency markerless DNA m anipulation in Escherichia coli. Biotechniques,2006,40(2):191 197. 
［17］ Wussow F, Fickenscher H, Tischer B K. Red mediated transposition and final release of the mini F vector of a cloned infectious herpesvirus genome. PLoS One,2009,4(12):e8178. 
［18］ Zhang Y, Buchholz F, Muyrers J P, et al. A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet,1998,20(2):123 128. 
［19］ Yang X W, Model P, Heintz N. Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome. Nat Biotechnol,1997,15(9):859 865. 
［20］ Kim S Y, Horrigan S K, Altenhofen J L, et al.Modification of bacterial artificial chromosome clones using Cre recombinase: introduction of selectable markers for expression in eukaryotic cells. Genome Res,1998,8(4):404 412. 
［21］ Song M J, Hwang S, Wong W H, et al. Identification of viral genes essential for replication of murine gamma herpesvirus 68 using signature tagged mutagenesis. Proc Natl Acad Sci USA,2005,102(10):3805 3810. 
［22］ Sadaoka T,Yoshii H,Imazawa T,et al. Deletion in open reading frame 49 of varicella zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts. J Virol,2007,81(22):12654 12665. 
［23］ Chaudhuri V, Sommer M, Rajamani J, et al. Functions of Varicella zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection. J Virol, 2008,82(20):10231 10246. 
［24］ Yamagishi Y, Sadaoka T, Yoshii H, et al.Varicella zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell to cell spread. J Virol,2008,82(2):795 804. 
［25］ Zhang Z, Huang Y, Zhu H. A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system. J Virol Methods,2008,148(1 2):197 204. 
［26］ Yoshii H, Sadaoka K, Matsuura M,et al. Varicella zoster virus ORF 58 gene is dispensable for viral replication in cell culture.Virol J,2008,30;5:54. 
［27］ Lowe R S, Keller P M, Keech B J, et al. Varicella zoster virus as a live vector for the expression of foreign genes. Proc Natl Acad Sci USA,1987,84(11):3896 3900. 
［28］ Shiraki K, HayakawaY, Mori H, et al. Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen. J Gen Virol,1991,72(Pt 6):1393 1399. 
［29］ Shiraki K, Sato H, Yoshida Y, et al. Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen. J Med Virol,2001,64(2):89 95. 
［30］ Heineman T C, Connelly B L, Bourne N, et al. Immunization with recombinant varicella zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs. J Virol,1995,69(12):8109 8113. 
［31］ Heineman T C, Pesnicak L, Ali M A, et al. Varicella zoster virus expressing HSV 2 glycoproteins B and D induces protection against HSV 2 challenge. Vaccine,2004,22(20):2558 2565. 
［32］ Somboonthum P, Yoshii H, Okamoto S, et al. Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin neuraminidase protein as a polyvalent live vaccine. Vaccine,2007,17,25(52):8741 8755.